ACVIM canine chronic valvular heart disease consensus statement

Vetmedin Solution from Boehringer Ingelheim is indicated for treatment of cases caused by myxomatous mitral valve disease or dilated cardiomyopathy and is the first oral solution approved by the FDA for this use in dogs

We have compiled a countdown of our top Vet Blast Podcast Episodes in 2023, here is number 9

Investigators developed an artificial intelligence algorithm that can discover and grade heart murmurs

Learn about the prevalence of myxomatous mitral valve disease, guidelines for staging heart disease, proactive diagnostic workup, the importance of spironolactone and aldosterone blocking, and the benefits of combination therapy for improved outcomes in canine patients

Seven key points for handling emergency situations with skill and confidence were covered in the day 3 keynote at the Fetch dvm360 Conference in Atlantic City.

Texas A&M cardiologists saved a beloved border collie from a third-degree atrioventricular block